参考文献/References:
[1] Martin E,Shapiro JR.Osteogenesis imperfecta:epidemiology and pathophysiology[J].Curr Osteoporos Rep,2007,5(3):91-97.
[2] Sillence DO,Senn A,Danks DM.Genetic het erogeneity in osteogenesis imperfecta[J].J Med Genet,1979,(16):101-116.
[3] Rauch F,Glorieux FH.Treatment of children with osteogenesis imperfecta[J].Lancet,2004,(363):1377-1385.
[4] Glorieux FH.Osteogenesis imperfecta[J].Best Pract Res Clin Rheu matol,2008,22(1):85-100.
[5] Plotkin H.Syndromes with congenital brittle bones[J].BMC Pediatr,2004,4(4):16.
[6] Daly K,Wisbeach A,Sanperal Jr,et al.The Prognosis for walking in osteogenesis imperfecta[J].J Bone Joint Surg Br,1996,78(3):477-480.
[7] Licata AA.Discovery,clinical development and therapeutic uses of bisphosphonates[J].Ann Pharmacother,2005,39(4):668-677.
[8] Vallo A,Rodriguez LF,Rodriguez SJ.Osteogenesis imperfect:anthropometric,skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy[J].Acta Paediatr,2006,(95):332-339.
[9] Zack P,Franck L,Devile C,et al.Fracture and non-fracture in children with osteogenesis imperfecta[J].Acta Paediatr,2005,94(9):1238-1242.
[10] Pizones J,Plotkin H,Parra-Garcia J,et al.Bone healing in children with osteogenesis imperfecta treated with imperfecta treated with bisphosphonates[J].J Pediatr Orthop,2005,25(3):332-325.
[11] Gajko-Galicka A.Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans[J].Acta Biochim Pol,2002,49(2):433-441.
[12] Chamberlain JR,Schwarze U,Wang PR,et al.Gene targeting in stem cells from individuals with osteogenesis imperfecta[J].Science,2004,303(5661):1198-1201.
[13] King D,Jarjoura D,McEwen HA,et al.Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta[J].J Bone Miner Res,2005,20(6):987-993.
[14] Letocha AD,Cintas HL,Troendle JF,et al.Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement[J].J Bone Miner Res,2005,20(6):977-986.
[15] 刘刚.鹿瓜多肽注射液治疗成骨不全症临床观察[J].中国骨与关节损伤杂志,2007,22(4):288.
[16] Saldanha M,Saleh M,Bell MJ,et al.Limb lengthening and correetion of deformity in the lower.Limbs of children with osteogenesis imperfecta[J].J Bone Joint Surg Br,2004,86(2):259-265.
[17] Javier P,Horacio P.Bone healing in children with OI treated with bisphosphonates[J].J Pediatr Orthop,2005,(4):332-334.
[18] Sofield H,Fragmentation ME.Realrgnment,and intramedullary rod fixation of deformities of the long bones in children:a ten-year appraisal[J].J Bone Joint Surg(Am),1959,(41):1371-1391.
[19] Li YH,Chow W,Long JC.The sofield millar operation in OI A modifield technique[J].J Bone Joint Surg Br,2000,82(1):11-16.
[20] WilkinSon JM,Scott BW,Clarke AM,et al.Surgical stabilisation of the lower limb in osteogenesis imperfecta.Using the Sheffield Telescopic Intramedullary Rod System[J].J Bone Joint Surg Br,1998,80(6):999-1004.
[21] 朱振洪,王晓东,王科文,等.髓内钉在矫治儿童成骨不全严重肢体畸形中的应用[J].中国矫形外科杂志,2006,14(9):657-659.
[22] 米川,马忠泰,周振兴,等.成骨不全伴重度肢体畸形的外科治疗及文献综述[C]//中华医学会骨科分会.中华医学会第八届骨科学术会议暨第一届国际COA学术大会论文摘要集,2006:261-262.
[23] Agarwal V,Joseph B.Non-union in osteogenesis imperfecta[J].J Pediatr Orthop B,2005,14(6):451-455.
[24] 李广玉,张涛,王宏鹤.家族性遗传性成骨不全2家系21例调查报告[J].中医正骨,1999,11(4):23-24.
[25] 薛恒,李钢,朱明义,等.成骨不全患儿骨折的治疗及康复体会[J].中国实用医药,2009,4(1):252-253.